Abbott: Hypertension trials

The registry lists 22 Hypertension studies with Abbott as lead sponsor. 0 are open to participants now and 10 have results posted.

Phase 2 3Phase 3 2Phase 4 5No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Observational Study of the EnligHTN Renal Denervation System in EuropeCompletedNCT02006758Results posted
• EnligHTN German Observational Study of Renal Denervation for Uncontrolled HypertensionCompletedNCT01996033Results posted
• EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for HypertensionTerminatedNCT01903187Not applicableResults posted
• IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNTerminatedNCT01705080Results posted
• Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential HypertensionCompletedNCT01631227Phase 3Results posted
• A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With EprosartanCompletedNCT01562613Results posted
• Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension PatientsCompletedNCT01438229Not applicableResults posted
• Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential HypertensionCompletedNCT01127139Results posted
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsCompletedNCT01078584Results posted
• The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery StenosisCompletedNCT00490841Not applicableResults posted
• An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 DiabetesCompletedNCT02298556
• International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled HypertensionCompletedNCT01836146Not applicable
• A Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study of Cardene® I.V. in Pediatric Subjects With HypertensionWithdrawnNCT00528827Phase 2
• A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)CompletedNCT00235014Phase 4
• Russian Study of the Efficacy and Safety of Tarka in Patients With HypertensionCompletedNCT00235001Phase 4
• Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)CompletedNCT00234871Phase 4
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)CompletedNCT00234858Phase 4
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)CompletedNCT00233532Phase 4
• Efficacy and Safety of Moxonidine in Indian PatientsCompletedNCT00160277Phase 3
• Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionCompletedNCT00160225Phase 2
• Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionCompletedNCT00160212Phase 2
• Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable